SMITHKLINE KYTRIL, FAMVIR COULD BE DIVESTMENT CANDIDATES IN MERGER WITH GLAXO; MERGER WOULD GIVE GLAXO ENTRY INTO PBM, CLINICAL LABS BUSINESSES

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".